Venatorx Pharmaceuticals
Pharmaceutical Manufacturer
Based in PA
AI Overview
With $260K in lobbying spend across 7 quarterly filings, Venatorx Pharmaceuticals is an active lobbying client. Their lobbying covers 1 issue area. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $140K |
| 2022 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Venatorx Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to advancing new federal incentives for the research and development of novel critical need antimicrobial products.
Issues related to healthcare.
Issues related to biopharmaceutical policy.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.